Community-Based Opioid Overdose Prevention Programs Providing Naloxone —United States, 2010
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Drug overdose death rates have increased steadily in the United States since 1979. In 2008, a total of 36,450 drug overdose deaths (i.e., unintentional, intentional [suicide or homicide], or undetermined intent) were reported, with prescription opioid analgesics (e.g., oxycodone, hydrocodone, and methadone), cocaine, and heroin the drugs most commonly involved (1). Since the mid-1990s, community-based programs have offered opioid overdose prevention services to persons who use drugs, their families and friends, and service providers. Since 1996, an increasing number of these programs have provided the opioid antagonist naloxone hydrochloride, the treatment of choice to reverse the potentially fatal respiratory depression caused by overdose of heroin and other opioids (2). Naloxone has no effect on non-opioid overdoses (e.g., cocaine, benzodiazepines, or alcohol) (3). In October 2010, the Harm Reduction Coalition, a national advocacy and capacity-building organization, surveyed 50 programs known to distribute naloxone in the United States, to collect data on local program locations, naloxone distribution, and overdose reversals. This report summarizes the findings for the 48 programs that completed the survey and the 188 local programs represented by the responses. Since the first opioid overdose prevention program began distributing naloxone in 1996, the respondent programs reported training and distributing naloxone to 53,032 persons and receiving reports of 10,171 overdose reversals. Providing opioid overdose education and naloxone to persons who use drugs and to persons who might be present at an opioid overdose can help reduce opioid overdose mortality, a rapidly growing public health concern. Overdose is common among persons who use opioids, including heroin users. In a 2002–2004 study of 329 drug users, 82% said they had used heroin, 64.6% had witnessed a drug overdose, and 34.6% had experienced an unintentional drug overdose (4). In 1996, community-based programs began offering naloxone and other opioid overdose prevention services to persons who use drugs, their families and friends, and service providers (e.g., health-care providers, homeless shelters, and substance abuse treatment programs). These services include education regarding overdose risk factors, recognition of signs of opioid overdose, appropriate responses to an overdose, and administration of naloxone. To identify local program locations and assess the extent of naloxone distribution, in October 2010 the Harm Reduction Coalition e-mailed an online survey to staff members at the 50 programs then known to distribute naloxone. Follow-up e-mails and telephone calls were used to encourage participation, clarify responses, and obtain information on local, community-based programs. The survey included questions about the year the program began distributing naloxone, the number of persons trained in overdose prevention and naloxone administration, the number of overdose reversals reported, and whether the totals were estimates or based on program data. The survey also asked questions regarding the naloxone formulations currently distributed, any recent difficulties in obtaining naloxone, and the program’s experience with naloxone distribution. Staff members at 48 (96%) of the 50 programs completed the online survey. Since the first program began distributing naloxone in 1996, through June 2010, the 48 responding programs reported providing training and distributing naloxone to an estimated 53,032 persons (program range: zero to 16,220; median: 102.5; mean: 1,104.8).* From the first naloxone distribution in 1996 through June 2010, the programs received reports of 10,171 overdose reversals using naloxone (range: zero to 2,385; median: 32; mean: 211.9).† During a recent 12-month period, respondents distributed an estimated 38,860 naloxone vials (Table).§ Using data from the survey, the number of programs beginning naloxone distribution each year during 1996–2010 was compared with the annual crude rates of unintentional drug overdose deaths per 100,000 population from 1979 to 2008 (Figure 1) (1). FIGURE 1 Annual crude rates* of unintentional drug overdose deaths and number of overdose prevention programs distributing naloxone — United States, 1979–2010 TABLE Number of opioid overdose programs/local programs, naloxone vials provided in a recent 12-month period, program participants overall, and overdose reversals, by program size — United States, 1996–2010 The 48 responding programs were located in 15 states and the District of Columbia. Four responding programs provided consolidated data for multiple local, community-based programs. Three state health departments, in New York, New Mexico, and Massachusetts, provided data for 129 local programs (65, 56, and eight, respectively); a nongovernmental organization in Wisconsin provided data on a statewide operation with 16 local programs. In all, the 48 respondin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pregnancy-related mortality surveillance--United States, 1991--1999.
Chang, J., Elam–Evans, L. D., Berg, C. J., Herndon, J. L., Flowers, L. M., Seed, K., & Syverson, C. (2003) · PubMed · Cited by 831
Pregnancy-Related Mortality in the United States, 1998 to 2005
Berg, C. J., Callaghan, W. M., Syverson, C., & Henderson, Z. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181fdfb11 · Cited by 688
Xu, J., Kochanek, K. D., Murphy, S. L., & Tejada‐Vera, B. (2010) · PubMed · Cited by 650
Goodman and Gilman's the pharmacologic basis of therapeutics
Scialli, A. R. (1991) · Reproductive Toxicology · doi:10.1016/0890-6238(91)90100-t · Cited by 603
Updated norovirus outbreak management and disease prevention guidelines.
Gregoricus, N., Hall, A. J., Lopman, B. A., et al. (2011) · PubMed · Cited by 427
Trends in Ectopic Pregnancy Mortality in the United States: 1980–2007
Creanga, A. A., Shapiro-Mendoza, C. K., Bish, C. L., Zane, S., Berg, C. J., & Callaghan, W. M. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182113c10 · Cited by 280
Saved by the nose: Bystander-administered intranasal naloxone hydrochloride for opioid overdose
Doe-Simkins, M., Walley, A. Y., Epstein, A., & Moyer, P. (2009) · American Journal of Public Health · doi:10.2105/ajph.2008.146647 · Cited by 250 · cited 2×
“7 ectopic pregnancies per 1,000 pregnancies in the United States for 1990–1992 was reported using inpatient National Hospital Discharge Survey and outpatient National Hospital Ambulatory Medical Care Survey data (5).”
Novel Surveillance Network for Norovirus Gastroenteritis Outbreaks, United States
Vega, E. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1708.101837 · Cited by 237
Trends in the Diagnosis and Treatment of Ectopic Pregnancy in the United States
Hoover, K. W., Tao, G., & Kent, C. K. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181d0c328 · Cited by 228
Project Lazarus: community-based overdose prevention in rural North Carolina
Albert, S., Brason, F. W., Sanford, C. K., Dasgupta, N., Graham, J., & Lovette, B. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01128.x · Cited by 210
Overdose Prevention and Naloxone Prescription for Opioid Users in San Francisco
Enteen, L., Bauer, J., McLean, R., Wheeler, E., Huriaux, E., Kral, A. H., & Bamberger, J. D. (2010) · Journal of Urban Health · doi:10.1007/s11524-010-9495-8 · Cited by 187
Estimates of the Annual Number of Clinically Recognized Pregnancies in the United States, 1981-1991
Saraiya, M., Berg, C. J., Shulman, H., Green, C. A., & Atrash, H. K. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009747 · Cited by 135
Perinatal and maternal mortality in a religious group avoiding obstetric care
Kaunitz, A. M., Spence, C., Danielson, T. S., Rochat, R. W., & Grimes, D. A. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(84)90457-5 · Cited by 124
Route of administration for illicit prescription opioids: a comparison of rural and urban drug users
Young, A. M., Havens, J. R., & Leukefeld, C. G. (2010) · Harm Reduction Journal · doi:10.1186/1477-7517-7-24 · Cited by 123
Overdoses among friends: Drug users are willing to administer naloxone to others
Lagu, T. C., Anderson, B. J., & Stein, M. D. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.05.010 · Cited by 106
Stopping an Invisible Epidemic: Legal Issues in the Provision of Naloxone to Prevent Opioid OverdosePreprint
Burris, S. C., Beletsky, L. A., Castagna, C. A., Coyle, C., Crowe, C., & McLaughlin, J. M. (2009) · SSRN Electronic Journal · doi:10.2139/ssrn.1434381 · Cited by 43
Opioid Harm Reduction Strategies: Focus on Expanded Access to Intranasal Naloxone
Wermeling, D. P. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.7.627 · Cited by 37
Cited by
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031914-122957 · Cited by 1,388
Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013) · BMJ · doi:10.1136/bmj.f174 · Cited by 999
Mortality Among Homeless Adults in Boston: Shifts in Causes of Death Over a 15-Year Period
Baggett, T. P., Hwang, S. W., O’Connell, J. J., Porneala, B. C., Stringfellow, E. J., Orav, E. J., Singer, D. E., & Rigotti, N. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1604 · Cited by 566
Medication-Assisted Treatment of Opioid Use Disorder: Review of the Evidence and Future Directions
Connery, H. S. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000075 · Cited by 576
Jones, C. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.01.007 · Cited by 517
Metadata
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2012-04-04
- Volume
- 307
- Issue
- 13
- Pages
- 1358
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2396158723
- Cited by
- 257
- References
- 17
- FWCI
- 32.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.